Novel sulfonamide-phosphonate conjugates as carbonic anhydrase isozymes inhibitors

被引:4
作者
Bekheit, Mohamed S. [1 ]
Sabry, Eman [1 ]
Mohamed, Hanan A. [2 ]
Ewies, Ewies F. [3 ]
Kariuki, Benson M. [4 ]
Fouad, Marwa A. [5 ,6 ]
Vullo, Daniela [7 ]
Supuran, Claudiu T. [7 ]
机构
[1] Natl Res Ctr, Dept Pesticide Chem, Giza, Egypt
[2] Natl Res Ctr, Appl Organ Chem Dept, Giza, Egypt
[3] Natl Res Ctr, Organometall & Organometalloid Chem Dept, Giza, Egypt
[4] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, Wales
[5] Cairo Univ, Fac Pharm, Pharmaceut Chem Dept, Cairo 11562, Egypt
[6] New Giza Univ, Sch Pharm, Pharmaceut Chem Dept, Cairo, Egypt
[7] Univ Florence, NEUROFARBA Dept, Sect Pharmaceut & Nutraceut Sci, Florence, Italy
关键词
anticancer; carbonic anhydrase inhibitor; one-pot reaction; sulfapyridine; alpha-aminophosphonate; DISCOVERY;
D O I
10.1002/ddr.22135
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The three-components one-pot Kabachnik-Fields reaction of sulfapyridine, diethyl phosphite, and aldehyde under thermal catalysis reaction condition in the presence of bismuth (III) triflate as a catalyst afford the corresponding sulfonamide-phosphonates (3a-3p) in good to excellent yields (78%-91%). The structures of the new synthesized compounds were elucidated and confirmed by variable spectroscopic studies. Single crystal X-ray studies for 3a, 3d, and 3i verified the proposed structure. The newly developed sulfonamide-phosphonates were evaluated for their inhibitory properties against four isoforms of human carbonic anhydrase (hCA I, II, IX, and XII). The results demonstrated that they exhibited greater potency in inhibiting hCA XII compared to hCA I, II, and IX, with Ki ranging from 5.1 to 51.1 nM. Compounds 3l and 3p displayed the highest potency, exhibiting selectivity ratios of I/XII >298.7 and 8.5, and II/XII ratios of 678.1 and 142.1, respectively. Molecular docking studies were conducted to explore their binding patterns within the binding pocket of CA XII. The results revealed that the sulfonamide NH group coordinated with the Zn2+ ion, and hydrogen bond interactions were observed with residue Thr200. Additionally, hydrophobic interactions were identified between the benzenesulfonamide phenyl ring and Leu198. Compounds 3p and 3l exhibited an additional hydrogen bonding interaction with other amino acid residues. These supplementary interactions may contribute to the enhanced potency and selectivity of these compounds toward the CA XII isoform.
引用
收藏
页数:12
相关论文
共 30 条
  • [1] Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI
    Alp, Cemalettin
    Ozsoy, Seyda
    Alp, Nurdan Alcan
    Erdem, Deryanur
    Gultekin, Mehmet Serdar
    Kufrevioglu, Omer Irfan
    Senturk, Murat
    Supuran, Claudiu T.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (06) : 818 - 824
  • [2] Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
    Alterio, Vincenzo
    Di Fiore, Anna
    D'Ambrosio, Katia
    Supuran, Claudiu T.
    De Simone, Giuseppina
    [J]. CHEMICAL REVIEWS, 2012, 112 (08) : 4421 - 4468
  • [3] Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
    Angeli, Andrea
    Kartsev, Victor
    Petrou, Anthi
    Lichitsky, Boris
    Komogortsev, Andrey
    Pinteala, Mariana
    Geronikaki, Athina
    Supuran, Claudiu T.
    [J]. PHARMACEUTICALS, 2022, 15 (03)
  • [4] Multi-Component Reactions in the Preparation of α- and β- Substituted Phosphonates
    Bekheit, Mohamed S.
    Kamel, Azza A.
    [J]. CURRENT ORGANIC CHEMISTRY, 2017, 21 (10) : 923 - 938
  • [5] Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies
    Bozdag, Murat
    Ferraroni, Marta
    Nuti, Elisa
    Vullo, Daniela
    Rossello, Armando
    Carta, Fabrizio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 334 - 340
  • [6] Sulfonamides: a patent review (2008-2012)
    Carta, Fabrizio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (07) : 747 - 758
  • [7] DrugBank, 2023, US
  • [8] Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors
    Ewies, Ewies F.
    Sabry, Eman
    Bekheit, Mohamed S.
    Fouad, Marwa A.
    Vullo, Daniela
    Supuran, Claudiu T.
    [J]. DRUG DEVELOPMENT RESEARCH, 2022, 83 (06) : 1281 - 1291
  • [9] Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers
    Ewies, Ewies F.
    El-Hussieny, Marwa
    El-Sayed, Naglaa F.
    Fouad, Marwa A.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 180 : 310 - 320
  • [10] A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization
    Guler, Ozen Ozensoy
    Capasso, Clemente
    Supuran, Claudiu T.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (05) : 689 - 694